NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/23/2026
Back to search
Official data from USPTO
PETERTHOMASROTH CLINICAL SKIN CARE PEPTIDE SKINJECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PETERTHOMASROTH CLINICAL SKIN CARE PEPTIDE SKINJECTION
ST13
US500000097913677Class
3
Filing
97913677
Registration
8315370
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
06/23/2026
Trademark type
Word
Nice classes
3
Filing date
04/28/2023
Registration date
06/23/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2026
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-11-00
First use in commerce
2023-11-00
Drawing code
4
Owner type
16
Owner location
New York, NY, US
Examiner
STIGLITZ, SUSAN R
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Peter Thomas Roth Labs, LLC
Representatives
Christine M. Baker Pierson Ferdinand LLP
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated skin care preparations
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/03/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/03/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/20/2026
IUAF
USE AMENDMENT FILED
01/16/2026
EISU
TEAS STATEMENT OF USE RECEIVED
01/16/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/16/2026
EX3G
SOU EXTENSION 3 GRANTED
01/15/2026
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
12/03/2025
NREV
NOTICE OF REVIVAL - E-MAILED
12/03/2025
PETG
PETITION TO REVIVE-GRANTED
12/03/2025
PROA
TEAS PETITION TO REVIVE RECEIVED
12/03/2025
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
10/07/2025
ABN6
ABANDONMENT - NO USE STATEMENT FILED
10/07/2025
EXT3
SOU EXTENSION 3 FILED
07/16/2025
EX2G
SOU EXTENSION 2 GRANTED
07/16/2025
EXT2
SOU EXTENSION 2 FILED
01/16/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/21/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/21/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/21/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/17/2024
EX1G
SOU EXTENSION 1 GRANTED
07/17/2024
EXT1
SOU EXTENSION 1 FILED
07/17/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/16/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2023
PUBO
PUBLISHED FOR OPPOSITION
11/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/19/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
10/19/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/19/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
10/19/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/19/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/18/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2023
DOCK
ASSIGNED TO EXAMINER
09/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/28/2023
NWAP
NEW APPLICATION ENTERED
05/02/2023
Continuous trademark protection
Get notified about every new filing that threatens PETERTHOMASROTH CLINICAL SKIN CARE PEPTIDE SKINJECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.